Q13113 (PDZ1I_HUMAN) Homo sapiens (Human)

PDZK1-interacting protein 1 UniProtKBInterProSTRINGInteractive Modelling

114 aa; Sequence (Fasta)

Available Structures

10 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of human SGLT1-MAP17 complex bound with LX2761 Heteromer
P13866;
22-55
1001YI;
Structure of human SGLT2-MAP17 complex bound with empagliflozin Heteromer
P31639;
26-55
100PLM;7R3;
Structure of human SGLT2-MAP17 complex with Dapagliflozin Heteromer
P31639;
28-56
100NAG;LE6;NA;
Structure of human SGLT2-MAP17 complex with TA1887 Heteromer
P31639;
28-56
100NAG;KZ3;NA;
Structure of human SGLT2-MAP17 complex with Sotagliflozin Heteromer
P31639;
28-56
100NAG;LFL;NA;
Structure of human SGLT2-MAP17 complex with Canagliflozin Heteromer
P31639;
28-56
100NAG;L3R;NA;
Structure of human SGLT2-MAP17 complex with Phlorizin Heteromer
P31639;
28-56
100NAG;LN9;
Structure of human SGLT2-MAP17 complex bound with substrate AMG in the occluded conformation Heteromer
P31639;
28-55
100GYP;
Structure of human SGLT1-MAP17 complex bound with substrate 4D4FDG in the occluded conformation Heteromer
P13866;
27-54
100KQC;
Structure of human SGLT2-MAP17 complex in the apo state in the inward-facing conformation Heteromer
P31639;
28-52
100

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7wmv.1.Bmonomer0.7522-55
99.12